Michael Egholm is the founder of Standard BioTools. Standard BioTools has raised $250M in total funding. Latest round: IPO.
Michael Egholm, formerly CTO of Danaher Life Sciences, became CEO and joined the Board of Directors at Fluidigm, which subsequently rebranded as Standard BioTools Inc. His role involves optimizing costs, driving growth, and expanding the company's market presence through strategic initiatives and acquisitions.
Full founder directory · Investor directory · Company funding database · Fundraising library